The Burden of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection among Hematology, Oncology, and Stem Cell Transplant Patients

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

(2014) Rajesh V. Lalla et al.   CANCER

Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update

(2014) Jonas Marschall et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module

(2013) Margaret A. Dudeck et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Improving the Central Line—Associated Bloodstream Infection Surveillance Definition: A Work in Progress

(2013) James P. Steinberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from a Field Test of a New National Healthcare Safety Network Definition

(2013) Isaac See et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Distribution of Pathogens in Central Line–Associated Bloodstream Infections among Patients with and without Neutropenia following Chemotherapy Evidence for a Proposed Modification to the Current Surveillance Definition

(2012) James P. Steinberg et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

(2012) Rachel J. Gibson et al.   SUPPORTIVE CARE IN CANCER

Guidelines for the prevention of intravascular catheter-related infections

(2011) Naomi P. O'Grady et al.   AMERICAN JOURNAL OF INFECTION CONTROL

CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?

(2011) T. G. Fraser et al.   CLINICAL INFECTIOUS DISEASES

Current Definitions of Central Line–Associated Bloodstream Infection Is the Emperor Wearing Clothes?

(2010) Daniel J. Sexton et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY